AU585940B2 - Lectin immunotoxins - Google Patents
Lectin immunotoxinsInfo
- Publication number
- AU585940B2 AU585940B2 AU53490/86A AU5349086A AU585940B2 AU 585940 B2 AU585940 B2 AU 585940B2 AU 53490/86 A AU53490/86 A AU 53490/86A AU 5349086 A AU5349086 A AU 5349086A AU 585940 B2 AU585940 B2 AU 585940B2
- Authority
- AU
- Australia
- Prior art keywords
- immunotoxins
- lectin
- lectin immunotoxins
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/30—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
- C07K16/3053—Skin, nerves, brain
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/68—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
- A61K47/6801—Drug-antibody or immunoglobulin conjugates defined by the pharmacologically or therapeutically active agent
- A61K47/6803—Drugs conjugated to an antibody or immunoglobulin, e.g. cisplatin-antibody conjugates
- A61K47/6811—Drugs conjugated to an antibody or immunoglobulin, e.g. cisplatin-antibody conjugates the drug being a protein or peptide, e.g. transferrin or bleomycin
- A61K47/6817—Toxins
- A61K47/6819—Plant toxins
- A61K47/6825—Ribosomal inhibitory proteins, i.e. RIP-I or RIP-II, e.g. Pap, gelonin or dianthin
- A61K47/6827—Ricin A
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/68—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
- A61K47/6835—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment the modifying agent being an antibody or an immunoglobulin bearing at least one antigen-binding site
- A61K47/6851—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment the modifying agent being an antibody or an immunoglobulin bearing at least one antigen-binding site the antibody targeting a determinant of a tumour cell
- A61K47/6865—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment the modifying agent being an antibody or an immunoglobulin bearing at least one antigen-binding site the antibody targeting a determinant of a tumour cell the tumour determinant being from skin, nerves or brain cancer cell
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Immunology (AREA)
- Animal Behavior & Ethology (AREA)
- Organic Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Cell Biology (AREA)
- Epidemiology (AREA)
- Molecular Biology (AREA)
- Toxicology (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Botany (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Neurosurgery (AREA)
- Oncology (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US06/654,613 US4590071A (en) | 1984-09-25 | 1984-09-25 | Human melanoma specific immunotoxins |
Publications (2)
Publication Number | Publication Date |
---|---|
AU5349086A AU5349086A (en) | 1987-08-20 |
AU585940B2 true AU585940B2 (en) | 1989-06-29 |
Family
ID=24625569
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU53490/86A Ceased AU585940B2 (en) | 1984-09-25 | 1986-02-14 | Lectin immunotoxins |
Country Status (2)
Country | Link |
---|---|
JP (1) | JPS62221700A (en) |
AU (1) | AU585940B2 (en) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4714759A (en) * | 1985-12-02 | 1987-12-22 | Whitaker Jr Robert B | Immunotoxin therapy of allergy |
AU626087B2 (en) * | 1987-07-17 | 1992-07-23 | Xoma Corporation | Improved immunotoxin therapies utilizing purified ricin a-chain species |
EP0622082A4 (en) * | 1992-07-28 | 1996-12-04 | Toray Industries | Immunocomplex. |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU6628386A (en) * | 1985-11-29 | 1987-07-01 | Consolidated Pharmaceuticals Limited | Ricin-antibody conjugates |
EP0232447A1 (en) * | 1986-02-13 | 1987-08-19 | Xoma Corporation | Lectin immunotoxins |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2437213A1 (en) * | 1978-09-28 | 1980-04-25 | Cm Ind | CYTOTOXIC PRODUCTS FORMED BY COVALENT BINDING OF THE CHAIN TO RICIN WITH AN ANTIBODY AND THEIR PREPARATION METHOD |
FR2504010B1 (en) * | 1981-04-15 | 1985-10-25 | Sanofi Sa | ANTI-CANCER MEDICINAL PRODUCTS CONTAINING THE RICIN-ASSOCIATED CHAIN ASSOCIATED WITH ANTIMELANOMA ANTIBODY AND PROCESS FOR THEIR PREPARATION |
-
1986
- 1986-02-14 AU AU53490/86A patent/AU585940B2/en not_active Ceased
- 1986-03-15 JP JP61058004A patent/JPS62221700A/en active Pending
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU6628386A (en) * | 1985-11-29 | 1987-07-01 | Consolidated Pharmaceuticals Limited | Ricin-antibody conjugates |
EP0232447A1 (en) * | 1986-02-13 | 1987-08-19 | Xoma Corporation | Lectin immunotoxins |
Also Published As
Publication number | Publication date |
---|---|
AU5349086A (en) | 1987-08-20 |
JPS62221700A (en) | 1987-09-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU4401185A (en) | Belastungsabhangig frequenzvariabler herzschrittmacher | |
AU4222285A (en) | Pyrrolobenzimidazoles | |
AU3839785A (en) | Sammelpackung | |
AU4254685A (en) | Arylhydroxamates | |
AU4256585A (en) | 1-heteroaryl-4-aryl-pyrazolin-5-ones | |
AU4105285A (en) | Tetrahydrofuran-2-ylmethylamines | |
AU3749685A (en) | Induktionsmotor | |
AU4061285A (en) | Schaltersicherungseinheit | |
AU579687B2 (en) | Indoles | |
AU4299085A (en) | Medizinisches schwingbett | |
AU4118385A (en) | Verbindungselement | |
AU4459585A (en) | Morpholinols | |
AU4422985A (en) | Leucotriene-antagonistic thioethehers | |
AU4357485A (en) | Injektionsspritze | |
AU4665085A (en) | Carbonyl phenyl-sulphonylguanidines | |
AU4271085A (en) | Metallophosphoaluminates | |
AU4274285A (en) | Cycloalkane-indene-carboximidamides | |
AU585940B2 (en) | Lectin immunotoxins | |
AU4061585A (en) | Automatisk fadolsaftapningsanlaeg | |
AU4216685A (en) | Aminocarnitines | |
AU4356785A (en) | Reinigungsburste | |
AU4223685A (en) | Azolylvinyl ethers | |
AU4163585A (en) | Benzothiopyranones | |
AU4271185A (en) | Ferrophosphoaluminates | |
AU4200785A (en) | Diamino - 6 - halogeno - 5 - alkylthio-pyrimidines |